Search Instructions:
* Filter the ENTIRE resource library: Choose a OR a to sort all resources.
* Choose Search Items : to filter one collection or perform complex queries.
* Choose Browse by Topic to search by one or more Topics.
Browse Items (92 total)
-
Creator: Bavari, Sina, and Patrick L. Iversen.
Subject: Research
Item Type: Publication
Date Last Updated: 2020-03-19
Description: Two phase 2 randomised clinical trials evaluating ChAd3-EBO-Z administered to healthy adults in Cameroon, Mali, Nigeria, and Senegal and healthy children in Mali and Senegal are reported by Milagritos Tapia and colleagues in The Lancet Infectious… -
Creator: Reisler, R. B., C. S. Kraft, S. Bavari, and A. P. Cardile
Subject: Research
Item Type: Publication
Date Last Updated: 2018-04-17
Description: "To the Editor—We read with interest the recent article in Clinical Infectious Diseases by Lanini et al, which focused on the relationship between human Ebola virus (EBOV) RNA and clinical chemistry values obtained during the West African outbreak in… -
Creator: University of Minnesota, Center for Infectious Disease Research and Policy
Subject: Treatment & Care
Item Type: Publication
Date Last Updated: 2017-01-17
Description: In the third major report from the Wellcome Trust–CIDRAP Ebola Vaccine Team B reflects on progress to date and the remaining challenges faced. -
Creator: Nelson, Roxanne.
Subject: Emergency Management
Item Type: Publication
Date Last Updated: 2020-04-17
Description: The impact of the ongoing pandemic of coronavirus 2019 on immunisation campaigns in low- and middle-income countries is concerning. Roxanne Nelson reports. -
Creator: The Medical Letter on Drugs and Therapeutics
Subject: Treatment & Care
Item Type: Publication
Date Last Updated: 2021-07-15
Description: COVID-19 Vaccine Comparison Chart (online only) effectiveness by vaccine and by variant. -
Creator: Dean, Natalie E., Pierre-Stéphane Gsell, Ron Brookmeyer, Forrest W. Crawford, Christl A. Donnelly, Susan S. Ellenberg, Thomas R. Fleming, M. Elizabeth Halloran, Peter Horby, Thomas Jaki, Philip R. Krause, Ira M. Longini, Sabue Mulangu, Jean-Jacques…
Subject: Emergency Management
Item Type: Publication
Date Last Updated: 2020-04-02
Description: Conducting trials of novel interventions during infectious disease emergencies, such as the ongoing Covid-19 pandemic, is increasingly recognized as important for determining the efficacy of potential vaccines and therapies. -
Creator: Ellebedy, A. H., K. J. Jackson, H. T. Kissick, H. I. Nakaya, C. W. Davis, K. M. Roskin, A. K. McElroy, C. M. Oshansky, R. Elbein, S. Thomas, G. M. Lyon, C. F. Spiropoulou, A. K. Mehta, P. G. Thomas, S. D. Boyd, and R. Ahmed
Subject: Research
Item Type: Publication
Date Last Updated: 2016-10
Description: Antigen-specific B cells bifurcate into antibody-secreting cells (ASCs) and memory B cells (MBCs) after infection or vaccination. -
Creator: Lurie, Nicole, Melanie Saville, Richard Hatchett, and Jane Halton.
Subject: Laboratory
Item Type: Publication
Date Last Updated: 2020-03-30
Description: The need to rapidly develop a vaccine against SARS-CoV-2 comes at a time of explosion in basic scientific understanding, including in areas such as genomics and structural biology, that is supporting a new era in vaccine development. -
Creator: Daniel, William, Marc Nivet, John Warner, and Daniel K. Podolsky.
Subject: Research
Item Type: Publication
Date Last Updated: 2021-05-20
Description: Emergency use authorizations for two messenger RNA (mRNA) vaccines — the BNT162b2 vaccine (Pfizer–BioNTech) and the mRNA-1273 vaccine (Moderna) — marked important milestones in efforts to respond to the coronavirus disease 2019 (Covid-19) pandemic.…Example only: NETEC provides this item for reference purposes but does not endorse its content. Newer versions may be in place at the providing institution.
-
Creator: CDC
Subject: Personnel Management
Item Type: Guide
Date Last Updated: 2019-04-16
Description: Recommendations for organizations sending US-based health care or emergency response workers to areas with Ebola outbreaks and predeparture assessment of any workers traveling from Ebola outbreak areas to the United States.